Blood Cancer Research & Clinical Trials
CONTACT US:713.790.2700
INTERNATIONAL:+1.713.441.2340
Find a Specialist Near You
Our pioneering research and many clinical trials result in new therapies developed to manage and cure blood cancer. Houston Methodist patients may have access to clinical trials offering potentially promising treatments not yet available to the public.
We use a comprehensive approach in blood cancer research across basic, clinical and population-based science. Our experts apply a combination of cutting-edge translational science techniques in the areas of personalized therapeutics and immunotherapy. This innovative approach enables us to develop novel therapeutics for hematologic cancer treatment and care so that patients do not have to travel elsewhere to receive this cutting-edge therapy.
Access to the Latest Advancements Sooner
If you need blood cancer treatment, participating in a clinical trial may be an option for you. A clinical trial can give you access to promising new treatment options sooner. You can also make a difference for people diagnosed with blood cancer in the future.
The benefits of participating in a clinical trial include:
- The opportunity to take part in research that will help our experts better understand your type of cancer, which may lead to new ways to prevent, detect and treat it in the future
- Being offered a new and potentially promising treatment that’s not yet available to the public
- Receiving care from oncology experts at one of the nation’s leading academic hospitals
Many of the standard treatments for blood cancer accepted and used today are based on the results of previous clinical trials. Not only have clinical trials paved the way for today’s standard of cancer care, but today’s trials will lead to standard of care for patients in future.
Clinical Trial FAQs
Blood Cancer Clinical Trials
You have access to new and potentially promising treatments close to home. Houston Methodist physicians support groundbreaking clinical trials for leukemia, lymphoma and multiple myeloma.
How to Join a Clinical Trial